Bill Miller Bristol Myers Squibb CO Transaction History
Miller Value Partners, LLC
- $234 Billion
- Q4 2024
A detailed history of Bill Miller (Miller Value Partners, LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Miller Value Partners, LLC holds 108,000 shares of BMY stock, worth $6.03 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
108,000
Previous 80,000
35.0%
Holding current value
$6.03 Million
Previous $4.14 Billion
47.58%
% of portfolio
2.61%
Previous 2.34%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...